Table 1 Clinical data of the subjects in the PE and control groups
From: Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
Control group | PE group | ||||
|---|---|---|---|---|---|
Number | 24 | 24 | |||
Age (years) | 32.04 ± 4.03 | 31.67 ± 4.65 | |||
Gestational age (weeks) | 36.17 ± 3.94 | 35.58 ± 3.63 | |||
Parity | 0(0–2) | 0(0–1) | |||
Gravidity | 2(1–3) | 1(1–3) |